Paul Neyman on: Scaling Clinical Trials with AI | Ep 1191

In this episode of The Digital Executive, Brian Thomas sits down with Paul Neyman, co-founder and Chief Revenue Officer of Areti Health, to explore how generative AI is reshaping clinical trials, patient engagement, and enterprise sales. Paul shares his journey from software engineer to sales leader and explains how his technical background helps him build credibility and close complex enterprise deals. He breaks down what’s broken in traditional clinical trial recruitment and how AI can automate patient matching, engagement, and scheduling at scale—dramatically reducing costs and accelerating timelines. Paul also reveals what Fortune 100 executives really want to see from AI platforms, including clear ROI, compliance guardrails, and real-world proof points. Finally, he looks ahead at how AI will transform sales organizations and the critical skills future CROs need to stay competitive.

If you liked what you heard today, please leave us a review - Apple or Spotify. 

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.